{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:57:14Z","timestamp":1780394234671,"version":"3.54.1"},"reference-count":155,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.1080\/17512433.2023.2173172","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:35:35Z","timestamp":1674837335000},"page":"119-131","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis"],"prefix":"10.1080","volume":"16","author":[{"given":"Ariana","family":"Moreno","sequence":"first","affiliation":[{"name":"Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Renert-Yuval","sequence":"additional","affiliation":[{"name":"Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA"},{"name":"Department of Dermatology and the Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[{"name":"Department of Dermatology and the Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra074081"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.03.150"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2007.06034"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1111\/all.12270"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00149-X"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.040"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.013"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.09.031"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1111\/all.15423"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.01.001"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.01.015"},{"issue":"6","key":"cit0012","first-page":"408","volume":"97","author":"Silverberg NB","year":"2016","journal-title":"Cutis"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0171-3"},{"key":"cit0014","volume-title":"The patient-reported disease burden in pediatric patients with atopic dermatitis (AD): a cross-sectional study in the United States (US), Canada, Europe, and Japan","author":"Weidinger S","year":"2020"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.251"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.12.020"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2017.02.002"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2004.00178.x"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.11.023"},{"key":"cit0020","volume-title":"RETRACTED: skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year","author":"Kelleher M","year":"2015"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.005"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32984-8"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.3943"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.1997.tb00135.x"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.09.009"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32983-6"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.060"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.032"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1027168"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.13-OA-0683"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S50476"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305799"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3000"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.030"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.alergo.2017.11.001"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010"},{"issue":"1","key":"cit0037","first-page":"116","volume":"71","author":"Eichenfield LF","year":"2014","journal-title":"Management and Treatment of Atopic Dermatitis with Topical Therapies. Journal of the American Academy of Dermatology."},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1564038"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13784"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.5.499"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12670"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-017-0140-6"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104878"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2008.00735.x"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1177\/000992280204100505"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0289"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4020231"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2006.00277.x"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13708"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1177\/000992280003900101"},{"issue":"2","key":"cit0051","first-page":"4","volume":"57","author":"Piacquadio D","year":"1996","journal-title":"Cutis"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12525553"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb02461.x"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203010-00005"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-017-0330-7"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1159\/000489125"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0607-9"},{"key":"cit0058","unstructured":"PROTOPIC\u00ae (tacrolimus) label"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12331"},{"issue":"1","key":"cit0060","first-page":"116","volume":"71","author":"Eichenfield LF","year":"2014","journal-title":"Management and Treatment of Atopic Dermatitis with Topical Therapies. Journal of the American Academy of Dermatology."},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903512156"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117525"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.574"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2007.06485.x"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12614216"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2008.02741.x"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109813"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2012.24.2.144"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14501"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00600.x"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2009.02.002"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200506020-00001"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70281-7"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.121832"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109812"},{"issue":"4","key":"cit0076","first-page":"8","volume":"8","author":"Lebwohl M","year":"2006","journal-title":"Medscape J Med"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.1.e2"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.064"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.08.046"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831030-00001"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61381-6"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.633"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.04.006"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.4305"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.075"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1116"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.010"},{"issue":"1","key":"cit0088","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/exd.13808","volume":"28","author":"Guttman\u2010Yassky E","year":"2019","journal-title":"Exp Dermatol"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.05.046"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2893"},{"issue":"12","key":"cit0091","first-page":"1394","volume":"14","author":"Spelman L","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"cit0092","volume-title":"Efficacy And safety of crisaborole in patients aged 3 months to 17 years with mild-to-moderate atopic dermatitis. American academy of Pediatrics Itasca","author":"Su JC","year":"2021"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0023"},{"issue":"4","key":"cit0094","first-page":"390","volume":"15","author":"Dina Coronado B","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"cit0095","first-page":"532","volume":"43","author":"D\u2019Ippolito D","year":"2018","journal-title":"Pharm Ther"},{"key":"cit0096","volume-title":"Dysbalance between the immune system and skin microbiome in chronic inflammatory dermatoses","author":"Kuchner M","year":"2021"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.022"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16348"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16928"},{"key":"cit0100","volume-title":"Press Release: FDA approves Dupixent\u00ae (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis","author":"Julie Block NP","year":"2022"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.10.010"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-020-00387-2"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19460"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3336"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13697"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1682503"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.08.051"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18179"},{"key":"cit0109","unstructured":"Julie Block NP, George D MD, Yancopoulos. Press Release: FDA approves Dupixent\u00ae (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis 2022 [Jul\/29\/2022]. Available from: https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2022\/2022-06-07-20-45-00-2458243#:~:text=June%207%2C%202022.,those%20therapies%20are%20not%20advisable."},{"key":"cit0110","volume-title":"HIGHLIGHTS OF PRESCRIBING INFORMATION DUPIXENT\u00ae (dupilumab) injection, for subcutaneous use Initial U.S. Approval","volume":"2019","author":"U.S. Food and Drug Administration","year":"2017"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0702-4"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.022"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"cit0115","volume-title":"Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder","author":"FDA Approves First","year":"2022"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.19330"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.802036"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0079"},{"key":"cit0120","unstructured":"Lilly\u2019s lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials 2021. [cited 2022 May 26]. Available from: https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-lebrikizumab-significantly-improved-skin-clearance-and"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00613-8"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.12.005"},{"key":"cit0123","first-page":"17","volume":"12","author":"Paller A","year":"2021","journal-title":"Age (Omaha)"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S267217"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19574"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20810"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.009"},{"key":"cit0128","unstructured":"U.S. FDA Approves RINVOQ\u00ae (upadacitinib) to treat adults and children 12 years and older with refractory, moderate to severe atopic dermatitis 2022. [cited 2022 Aug 6]. Available from: https:\/\/news.abbvie.com\/news\/press-releases\/us-fda-approves-rinvoq-upadacitinib-to-treat-adults-and-children-12-years-and-older-with-refractory-moderate-to-severe-atopic-dermatitis.htm"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00588-2"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.07.036"},{"key":"cit0131","unstructured":"HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to useOPZELURA cream safely and effectively. [cited 2022 May 2]. Available from: https:\/\/www.opzelura.com\/prescribing-information.pdf"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.04.085"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.501"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.502"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.728"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.021"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.042"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S287638"},{"key":"cit0139","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12314"},{"key":"cit0140","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13781"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13209"},{"key":"cit0142","volume-title":"Comprehensive dermatologic drug therapy","author":"Wolverton SE","year":"2019"},{"key":"cit0143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.001"},{"key":"cit0144","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04922.x"},{"key":"cit0145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01488.x"},{"key":"cit0146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.003"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90281-9"},{"key":"cit0148","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12367"},{"key":"cit0149","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12592"},{"key":"cit0150","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969030-00005"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.12.005"},{"key":"cit0152","unstructured":"HIGHLIGHTS OF PRESCRIBING INFORMATION CELLCEPT (mycophenolate mofetil) capsules, for oral use"},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03667.x"},{"key":"cit0154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07947.x"},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124090-00002"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2023.2173172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:58:52Z","timestamp":1701802732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2023.2173172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"alternative-id":["10.1080\/17512433.2023.2173172"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2023.2173172","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}